There have been 50 recent insider transactions recorded for Roivant Sciences Ltd. (ROIV), including 1 buy and 48 sells. Total insider buying was valued at $3.94M and total insider selling at $255.11M.
Notable insiders with recent activity include Sukhatme Mayukh, Gline Matthew, Torti Frank. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ROIV
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-31 |
Sukhatme Mayukh |
President & CIO |
Tax Withholding of RSU |
187,512 |
$27.70 |
$5.19M |
18,677,617 |
| 2026-03-31 |
Gline Matthew |
CEO |
Tax Withholding of RSU |
304,684 |
$27.70 |
$8.44M |
17,025,890 |
| 2026-03-31 |
Torti Frank |
President and Vant Chair |
Tax Withholding of RSU |
160,035 |
$27.70 |
$4.43M |
13,576,512 |
| 2026-03-30 |
Sukhatme Mayukh |
President & CIO |
Option Exercise (Sell) |
1,306,889 |
- |
- |
- |
| 2026-03-30 |
Gline Matthew |
CEO |
Option Exercise (Sell) |
2,178,150 |
- |
- |
- |
| 2026-03-26 |
Fitzgerald Meghan |
Director |
Informative Sell |
70,000 |
$27.45 |
$1.92M |
42,963 |
| 2026-03-20 |
Pulik Richard |
CFO |
Tax Withholding of RSU |
1,546 |
$27.70 |
$42.82K |
236,867 |
| 2026-03-20 |
Humes Jennifer |
Chief Accounting Officer |
Tax Withholding of RSU |
14,526 |
$27.70 |
$402.37K |
97,729 |
| 2026-03-17 |
Venker Eric |
President & Immunovant CEO |
Informative Sell |
200,000 |
$28.24 |
$5.65M |
1,647,546 |
| 2026-03-16 |
Epperly Melissa B, |
Director |
Informative Sell |
41,861 |
$28.68 |
$1.2M |
15,804 |
| 2026-02-23 |
Torti Frank |
President and Vant Chair |
Option Exercise (Sell) |
587,390 |
$3.85 |
$2.26M |
3,026,184 |
| 2026-02-20 |
Torti Frank |
President and Vant Chair |
Option Exercise (Sell) |
1,012,610 |
$3.85 |
$3.9M |
3,613,574 |
| 2026-02-20 |
Venker Eric |
President & Immunovant CEO |
Tax Withholding of RSU |
7,051 |
$27.15 |
$191.43K |
1,647,546 |
| 2026-02-20 |
Pulik Richard |
CFO |
Tax Withholding of RSU |
1,000 |
$27.15 |
$27.15K |
238,413 |
| 2026-02-19 |
Torti Frank |
President and Vant Chair |
Option Exercise (Sell) |
1,400,000 |
$3.85 |
$5.39M |
4,626,184 |
| 2026-02-13 |
Manchester Keith S |
Director |
Informative Sell |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Qvt Financial Lp |
Other: Director By Deputization |
Informative Sell |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Gold Daniel Allen |
Director |
Informative Sell |
225,000 |
$26.50 |
$5.96M |
15,127,329 |
| 2026-02-13 |
Venker Eric |
President & Immunovant CEO |
Informative Sell |
200,000 |
$26.49 |
$5.3M |
1,654,597 |
| 2026-02-12 |
Manchester Keith S |
Director |
Informative Sell |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Qvt Financial Lp |
Other: Director By Deputization |
Informative Sell |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-12 |
Gold Daniel Allen |
Director |
Informative Sell |
275,000 |
$26.76 |
$7.36M |
15,503,113 |
| 2026-02-11 |
Manchester Keith S |
Director |
Informative Sell |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Qvt Financial Lp |
Other: Director By Deputization |
Informative Sell |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-11 |
Gold Daniel Allen |
Director |
Informative Sell |
425,000 |
$26.67 |
$11.33M |
15,928,113 |
| 2026-02-09 |
Sukhatme Mayukh |
President & CIO |
Option Exercise (Sell) |
651,558 |
$12.68 |
$8.26M |
- |
| 2026-01-20 |
Momtazee James C |
Director |
Tax Withholding of RSU |
122 |
$22.98 |
$2.8K |
109,030 |
| 2026-01-20 |
Oren Ilan |
Director |
Tax Withholding of RSU |
124 |
$22.98 |
$2.85K |
119,428 |
| 2026-01-20 |
Epperly Melissa B, |
Director |
Tax Withholding of RSU |
54 |
$22.98 |
$1.24K |
57,665 |
| 2026-01-12 |
Venker Eric |
President & Immunovant CEO |
Informative Sell |
200,000 |
$21.92 |
$4.38M |
1,654,597 |
| 2025-12-31 |
Sukhatme Mayukh |
President & CIO |
Option Exercise (Sell) |
2,449,877 |
$12.68 |
$31.06M |
95,718 |
| 2025-12-29 |
Sukhatme Mayukh |
President & CIO |
Option Exercise (Sell) |
748,358 |
$12.68 |
$9.49M |
555,840 |
| 2025-12-24 |
Torti Frank |
President and Vant Chair |
Gift (Given) |
110,489 |
- |
- |
13,736,547 |
| 2025-12-24 |
Venker Eric |
President & Immunovant CEO |
Informative Sell |
75,000 |
$22.53 |
$1.69M |
1,654,597 |
| 2025-12-23 |
Torti Frank |
President and Vant Chair |
RSU Award |
175,380 |
$22.45 |
$3.94M |
13,911,927 |
| 2025-12-23 |
Venker Eric |
President & Immunovant CEO |
Informative Sell |
200,000 |
$22.45 |
$4.49M |
1,611,749 |
| 2025-12-23 |
Pulik Richard |
CFO |
Informative Sell |
146,731 |
$22.39 |
$3.29M |
239,413 |
| 2025-12-20 |
Pulik Richard |
CFO |
Tax Withholding of RSU |
2,129 |
$22.41 |
$47.71K |
386,144 |
| 2025-12-17 |
Manchester Keith S |
Director |
Informative Sell |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Qvt Financial Lp |
Other: Director By Deputization |
Informative Sell |
155,076 |
$23.02 |
$3.57M |
16,542,651 |
| 2025-12-17 |
Gold Daniel Allen |
Director |
Informative Sell |
189,538 |
$23.17 |
$4.39M |
16,353,113 |
| 2025-12-17 |
Sukhatme Mayukh |
President & CIO |
Option Exercise (Sell) |
59,513 |
$12.68 |
$754.62K |
1,304,198 |
| 2025-12-16 |
Manchester Keith S |
Director |
Informative Sell |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Qvt Financial Lp |
Other: Director By Deputization |
Informative Sell |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-12-16 |
Gold Daniel Allen |
Director |
Informative Sell |
642,282 |
$23.08 |
$14.82M |
17,130,445 |
| 2025-06-20 |
Ramaswamy Vivek |
10 Percent Owner |
Informative Sell |
577,007 |
$11.46 |
$6.61M |
37,284,108 |
| 2025-06-20 |
Venker Eric |
President & COO |
Informative Sell |
100,000 |
$11.45 |
$1.15M |
1,462,223 |
| 2025-06-20 |
Pulik Richard |
CFO |
Tax Withholding of RSU |
1,503 |
$11.45 |
$17.21K |
399,056 |
| 2025-06-18 |
Ramaswamy Vivek |
10 Percent Owner |
Informative Sell |
565,266 |
$11.45 |
$6.47M |
37,861,115 |
| 2025-06-06 |
Ramaswamy Vivek |
10 Percent Owner |
Informative Sell |
200,800 |
$11.19 |
$2.25M |
38,426,381 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
